Fingerprint
Dive into the research topics of 'Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors
Douglas J. Norman, Flavio Vincenti, Angelo M. De Mattos, John M. Barry, Daniel J. Levitt, Nancy I. Wedel, Mauricio Maia, Susan E. Light
Research output: Contribution to journal › Article › peer-review
73
Scopus
citations